Penfill and liver function test abnormal Patient Reports February 13, 2012

Penfill Side Effects Report #4639147-3
Penfill side effect was reported by a Physician from on Apr 08, 2005. Male patient, 45 years of age, weighting 127.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: gamma-glutamyltransferase increased, hepatitis c antibody positive, liver function test abnormal. Penfill dosage: unknown. During the same period patient was treated with GLIBENCLAMIDE, HUMULIN R. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #4639186-2
Penfill side effect was reported by a Consumer or non-health professional from on Apr 08, 2005. Male patient, 45 years of age, weighting 127.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, liver function test abnormal. Penfill dosage: unknown. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #4877230-8
Penfill side effect was reported by a Consumer or non-health professional from JAPAN on Apr 08, 2005. Male patient, 45 years of age, weighting 127.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, liver function test abnormal. Penfill dosage: unknown. Patient was hospitalized. Patient recovered.